Pharma Aids Valuation

Is PHARMAID undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PHARMAID when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PHARMAID (BDT602.9) is trading above our estimate of fair value (BDT22.26)

Significantly Below Fair Value: PHARMAID is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PHARMAID?

Key metric: As PHARMAID is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for PHARMAID. This is calculated by dividing PHARMAID's market cap by their current earnings.
What is PHARMAID's PE Ratio?
PE Ratio	27.9x
Earnings	৳67.38m
Market Cap	৳1.88b

PHARMAID key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	4.3x
Enterprise Value/EBITDA	19.1x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does PHARMAID's PE Ratio compare to its peers?

The above table shows the PE ratio for PHARMAID vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	61.3x
KDSALTD KDS Accessories	16.4x	n/a	৳2.6b
DESHBANDHU Deshbandhu Polymer	28.4x	n/a	৳1.0b
SINOBANGLA Sinobangla Industries	28.4x	n/a	৳1.1b
WATACHEM Wata Chemicals	172x	n/a	৳1.7b
PHARMAID Pharma Aids	27.9x	n/a	৳1.9b

Price-To-Earnings vs Peers: PHARMAID is good value based on its Price-To-Earnings Ratio (27.9x) compared to the peer average (61.3x).

Price to Earnings Ratio vs Industry

How does PHARMAID's PE Ratio compare vs other companies in the Asian Packaging Industry?

6 Companies	Price / Earnings	Estimated Growth	Market Cap

6 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: PHARMAID is expensive based on its Price-To-Earnings Ratio (27.9x) compared to the Asian Packaging industry average (17.5x).

Price to Earnings Ratio vs Fair Ratio

What is PHARMAID's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PHARMAID PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	27.9x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate PHARMAID's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.